Endoplasmic reticulum stress and intestinal inflammation
Endoplasmic reticulum stress and intestinal inflammation
批准号:
10379412
负责人:
Richard S Blumberg
金额:
$65.9万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-05-01 至 2024-03-31
关键词:
AddressAdhesionsAffectAutophagocytosisBacteriaBacteroides fragilisBindingBinding ProteinsCell physiologyCellsClostridium difficileColitisDevelopmentDimensionsEndoplasmic ReticulumEpithelialEpithelial CellsExperimental ModelsFusobacteriumGeographic LocationsGoalsHomeostasisImmuneImmune responseIn VitroInflammationInflammatory Bowel DiseasesInterleukin-6IntestinesLeadLectinLightMediatingMetabolic syndromeMethodsMicrobeMissionModelingMucous MembraneMusNational Institute of Diabetes and Digestive and Kidney DiseasesNeoplasmsObesityOrganismOutcomePaneth CellsPathway interactionsPhysiologicalPlayPredispositionProductionProteinsPublic HealthRegulationResearchResearch ProposalsRiskRisk FactorsRoleSterilityStressTechniquesTestingTherapeuticTimeTissuesendoplasmic reticulum stressenteric infectionenteric pathogenenteritisgenetic risk factorglucose-regulated proteinsgut inflammationin vivoinhibitorinsightintestinal epitheliummetabolic phenotypemicrobialmicrobiomemicrobiotanovelobesity treatmentpathobiontrelease factorresponseselective expressiontooltransmission processtreatment strategy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Although the unfolded protein response (UPR) as a consequence of endoplasmic reticulum (ER) stress emanat-
ing from an intestinal epithelial cell (IEC) is well recognized to promote inflammation, little is known about the
ways that an IEC-derived UPR regulates other non-canonical functions. Recently, we discovered that an IEC-
associated UPR can regulate transmission of factors into the tissues or intestinal lumen that affect immune
responses or the composition of the microbiota, respectively. The current research proposal addresses the un-
answered question of how the UPR mediated regulation of factors involved in immune and microbiota function
are important to inflammatory bowel disease (IBD), metabolic syndrome and susceptibility to enteropathogens.
Our long-term goals are to parse out the specific mechanisms and consequences of UPR-mediated regulation
of factors involved in immune and microbiota function important to these (patho)physiologic activities. The ob-
jective of this research is to specifically define how an IEC-associated UPR can cause the sterile induction of
Thelper17 (TH17) cells in tissues or regulate the luminal microbiome through affecting intelectin-1 (ITLN1) pro-
duction, an elusive microbial lectin of poorly understood activity, that is increased in IBD and decreased in obe-
sity. Our central hypothesis is that IEC-associated ER stress regulates the release of factors which affect a
variety of physiologic functions important to immune development and regulation of the microbiome. The ra-
tionale for our proposed research is that developing such insights into these mechanisms will shed important
light on how they might lead to new perspectives on elucidating the role played by IEC-associated ER stress in
regulating TH17 cell development through control of interleukin-6 and IEC-derived ITLN1 function as a risk factor
for IBD and metabolic syndrome through the control of specific microbes. Our central hypothesis will be tested
with three specific aims: 1) define the involvement of IEC ER stress in the sterile induction of TH17 cells; 2)
identify how IEC-associated ER stress affects ITLN1 regulation of the microbiome, and; 3) characterize the con-
sequences of ITLN1-deficiency on immunometabolic function. In Aim 1 we will use a newly developed model of
ER stress induction through selective expression of a glucose-regulated protein 78 (GRP78) inhibitor in the ER
and other models to reveal how a UPR in the IEC instructs intestinal TH17 cell development independently of
microbiota and the role played in microbial TH17 induction. Aim 2 will define ITLN1 as a UPR-regulated, IEC-
derived lectin which binds a limited range of pathobionts using a newly developed technique of ITLN1-Seq and
how this regulates the induction of colitis. Aim 3 will provide direct evidence that ITLN1 regulation of specific
microbiota will act as a causal factor in obesity. Overall, this proposal is significant because it will allow us to
understand how IEC-associated ER stress broadcasts itself into the tissues or lumen to regulate the host and/or
the microbiota, respectively, and provide new dimensions on our understanding of several non-canonical activi-
ties of an IEC-associated UPR.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
2016 Antibody Biology and Engineering Gordon Research Conference & Gordon Research Seminar
-
批准号:9051582
-
项目类别:
-
资助金额:$0.4万
-
财政年份:2016
-
负责人:Richard S Blumberg
-
依托单位:
Endoplasmic reticulum stress and intestinal inflammation
-
批准号:8278604
-
项目类别:
-
资助金额:$54.6万
-
财政年份:2010
-
负责人:Richard S Blumberg
-
依托单位:
Endoplasmic reticulum stress and intestinal inflammation
-
批准号:8465875
-
项目类别:
-
资助金额:$51.14万
-
财政年份:2010
-
负责人:Richard S Blumberg
-
依托单位:
Endoplasmic reticulum stress and intestinal inflammation
-
批准号:10597650
-
项目类别:
-
资助金额:$65.9万
-
财政年份:2010
-
负责人:Richard S Blumberg
-
依托单位:
Endoplasmic reticulum stress and intestinal inflammation
-
批准号:9096752
-
项目类别:
-
资助金额:$64.77万
-
财政年份:2010
-
负责人:Richard S Blumberg
-
依托单位:
Endoplasmic reticulum stress and intestinal inflammation
-
批准号:9341213
-
项目类别:
-
资助金额:$63.09万
-
财政年份:2010
-
负责人:Richard S Blumberg
-
依托单位:
Endoplasmic reticulum stress and intestinal inflammation
-
批准号:7877159
-
项目类别:
-
资助金额:$70.45万
-
财政年份:2010
-
负责人:Richard S Blumberg
-
依托单位:
Endoplasmic reticulum stress and intestinal inflammation
-
批准号:8064351
-
项目类别:
-
资助金额:$55.96万
-
财政年份:2010
-
负责人:Richard S Blumberg
-
依托单位:
Regulation of Mucosal Lymphocytes
-
批准号:7917834
-
项目类别:
-
资助金额:$12.26万
-
财政年份:2009
-
负责人:Richard S Blumberg
-
依托单位:
14th International Congress of Mucosal Immunology
-
批准号:7753404
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2009
-
负责人:Richard S Blumberg
-
依托单位:
Anti CD40L therapy in inflammatory bowel disease
-
批准号:6353472
-
项目类别:
-
资助金额:$22.93万
-
财政年份:2000
-
负责人:Richard S Blumberg
-
依托单位:
CORE--IMMUNOLOGY AND MICROBIOLOGY
-
批准号:6349085
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2000
-
负责人:Richard S Blumberg
-
依托单位:
Anti CD40L therapy in inflammatory bowel disease
-
批准号:6227341
-
项目类别:
-
资助金额:$22.93万
-
财政年份:1999
-
负责人:Richard S Blumberg
-
依托单位:
CORE--IMMUNOLOGY AND MICROBIOLOGY
-
批准号:6198248
-
项目类别:
-
资助金额:$20.0万
-
财政年份:1999
-
负责人:Richard S Blumberg
-
依托单位:
BIOLOGY OF AN MHC CLASS I ASSOCIATED MOLECULE
-
批准号:2862818
-
项目类别:
-
资助金额:$3.56万
-
财政年份:1998
-
负责人:Richard S Blumberg
-
依托单位:
Regulation of Mucosal Lymphocytes
-
批准号:10667671
-
项目类别:
-
资助金额:$71.21万
-
财政年份:1998
-
负责人:Richard S Blumberg
-
依托单位:
Regulation of Mucosal Lymphocytes
-
批准号:8332756
-
项目类别:
-
资助金额:$60.33万
-
财政年份:1997
-
负责人:Richard S Blumberg
-
依托单位:
INTESTINAL TRANSCYTOSIS OF IgG IN ADULT LIFE
-
批准号:6621058
-
项目类别:
-
资助金额:$39.43万
-
财政年份:1997
-
负责人:Richard S Blumberg
-
依托单位:
Regulation of Mucosal Lymphocytes
-
批准号:6635068
-
项目类别:
-
资助金额:$30.49万
-
财政年份:1997
-
负责人:Richard S Blumberg
-
依托单位:
Intestinal Immune Regulation by IgG and FcRn
-
批准号:8391948
-
项目类别:
-
资助金额:$50.72万
-
财政年份:1997
-
负责人:Richard S Blumberg
-
依托单位:
海外基金